券商2026年2月"金股"名单出炉。据中国证券报记者不完全统计，截至2月2日发稿时，已有超过200只A 股及港股标的入围券商2月"金股"名单。从推荐频次看，阿里巴巴-W、腾讯控股、紫金矿业 （601899）、中际旭创（300308）、中国平安等标的推荐频次居前。 作为港股市场明星标的，截至2月2日记者发稿，阿里巴巴-W已入围6家券商2月"金股"组合，是机构青 睐标的，看好的券商包括光大证券、华源证券、兴业证券、国盛证券（002670）、申万宏源证券 （000562）、国信证券。从推荐理由看，华源证券认为，阿里巴巴-W云业务高速增长，市场份额领 先；C端AI产品打通生态，用户量快速增长；大模型研发顺利，性能持续提升。 包括阿里巴巴-W在内，截至2月2日记者发稿时，已有201只A股及H股标的入围券商2月"金股"名单，腾 讯控股2月共获得5家券商联合推荐，看好的券商包括光大证券、中国银河（601881）、国盛证券、国联 民生（601456）、申万宏源证券；福斯特（603806）、中际旭创、紫金矿业均获得4家券商联合推荐， 关注度相对较高。 从券商2月"金股"行业分布情况看，电子行业继续成为含"金"量最高的板块，合计 ...

来源：中保新知 国内大型险企或首次迎来特别国债注资。 据媒体消息，中国大型保险公司将迎来2000亿元特别国债的注资，相关计划最早可能于今年一季度公 布。如果消息属实并落地，这将是我国首次通过发行特别国债向险企注资。 事实上，早在2025年5月7日国新办发布会上，金融监管总局局长李云泽就曾透露，"金融监管总局引导 行业深入推进降本增效可持续发展的基础进一步夯实，完善资本补充机制，大型商业银行资本补充工作 正在加快实施，大型保险集团资本补充已经提上日程，各地也正在多渠道有序补充中小金融机构资本 金，这些措施将进一步增强金融体系的韧性和服务高质量发展的能力"。 2025年，四大国有银行就已经先行迎来特别国债注资。如今，市场传出特别国债注资大型保险机构似乎 也并不意外。 01 特别国债开闸 有外媒消息称，中国2000亿元特别国债将用来为头部保险公司注入资本，包括中国人寿、中国人保、中 国太平等国有险企。 有业内人士表示，大型险企未来或将承担更多责任协助处置弱资质同业的风险，而监管也一直在推动包 括险资在内的中长期资金入市。 事实上，中国在2025年已经发行5000亿元特别国债为中国银行、中国建设银行、交通银行、中国邮 ...

Core Insights - The report indicates that after a period of volatility, the market is expected to regain momentum in February, supported by a decrease in the volatility index from a peak of 102 to around 32, which is historically low [2][3] - The report emphasizes the importance of focusing on two main investment themes: technology growth and cyclical recovery, as funds are likely to rotate towards underperforming sectors [3][4] Investment Themes - **Technology Growth**: The AI industry is experiencing significant positive changes, with expectations for OAI listings and advancements in storage, CPU, and packaging sectors. The report highlights the importance of monitoring policy catalysts and industry developments, particularly in emerging sectors like aerospace, new materials, and quantum technology [6][6] - **Cyclical Recovery**: The report suggests that sectors such as chemicals, real estate, and core consumer assets are expected to see a rebound as market sentiment improves. The report notes that these sectors are currently at low points in their economic cycles, with potential for recovery as institutional positions are historically low [6][6] Recommended Stocks - **Jingsheng Electromechanical (300316.SZ)**: The company is positioned to benefit from increasing demand in space and overseas photovoltaic equipment, with a market cap of 58.3 billion and projected EPS growth from 0.95 in 2026 to 1.17 in 2027 [7][7] - **Nuwai Co., Ltd. (603699.SH)**: As a leading industrial valve manufacturer, the company is expected to see growth driven by LNG and marine vessel demand, with a projected EPS increase from 2.51 in 2026 to 3.00 in 2027 [7][7] - **Longjing Environmental Protection (600388.SH)**: The company is focusing on green electricity and energy storage, with a projected EPS growth from 1.20 in 2026 to 1.37 in 2027 [7][7] - **Chip Microelectronics (688630.SH)**: The company anticipates significant profit growth, with EPS expected to rise from 4.18 in 2026 to 6.08 in 2027 [7][7] - **AVIC High-Tech (600862.SH)**: The company is expected to benefit from the increasing demand for aerospace materials, with projected EPS growth from 1.17 in 2026 to 1.29 in 2027 [7][7] - **Ping An Insurance (601318.SH)**: The company is projected to maintain strong growth in new business value (NBV), with EPS expected to rise from 8.59 in 2026 to 9.74 in 2027 [7][7] - **Rabbit Baby (002043.SZ)**: The company is expected to see steady growth in the decorative board industry, with projected EPS growth from 1.05 in 2026 to 1.15 in 2027 [7][7] - **Wanhua Chemical (600309.SH)**: The company is expected to benefit from improving MDI and TDI market conditions, with projected EPS growth from 5.13 in 2026 to 5.79 in 2027 [7][7] - **Tianfu Communication (300394.SZ)**: The company is positioned to benefit from the demand for optical modules, with projected EPS growth from 4.10 in 2026 to 5.38 in 2027 [7][7] - **Shaanxi Tourism (603402.SH)**: The company is expected to see growth driven by its core tourism operations, with projected EPS growth from 6.65 in 2026 to 7.61 in 2027 [7][7]

一、沪深股通前十大成交 今日沪股通总成交金额为1737.74亿，深股通总成交金额为1845.36亿。 | | 沪股道( | 2月2日 D | | | --- | --- | --- | --- | | 排名 | 股票代码 | 股票名称 | 成交金额(亿元) | | 1 | 601899 | 三十年年 | 43.39 | | 2 | 600519 | 贵州茅台 | 41.83 | | 3 | 601318 | 中国平安 | 23.21 | | 4 | 688008 | 澜起科技 | 21.79 | | 5 | 600487 | 草通光电 | 17.76 | | 6 | 603986 | 兆易创新 | 17.62 | | 7 | 601138 | 工业富联 | 15.96 | | 8 | 666809 | 洛阳铝水 | 14.45 | | 9 | 600036 | 招商银行 | 13.51 | | 10 | 601600 | 中国铝业 | 13.27 | | | 深胺適( | 2月2日 ) | | | 排名 | 股票代码 | 股票名称 | 成交金额(亿元) | | 1 | 300308 | 中际旭创 | 57.7 ...

蓝筹股方面，腾讯控股跌1.24%，收报598.5港元；香港交易所跌1.85%，收报424.2港元；中国移动 跌2.26%，收报78港元；汇丰控股跌1.39%，收报134.7港元。 香港本地股方面，长实集团跌2.71%，收报44.6港元；新鸿基地产跌4.3%，收报120.3港元；恒基地 产跌0.71%，收报30.9港元。 新华社香港2月2日电 香港恒生指数2日跌611.54点，跌幅2.23%，收报26775.57点。全日主板成交 3478.86亿港元。 国企指数跌236.9点，收报9080.19点，跌幅2.54%。恒生科技指数跌191.87点，收报5526.31点，跌 幅3.36%。 中资金融股方面，中国银行跌1.07%，收报4.62港元；建设银行跌1.01%，收报7.83港元；工商银行 跌1.23%，收报6.41港元；中国平安跌2.75%，收报70.7港元；中国人寿跌3.96%，收报33.5港元。 石油石化股方面，中国石油化工股份跌2.42%，收报5.25港元；中国石油股份跌3.56%，收报8.95港 元；中国海洋石油跌4.76%，收报23.22港元。 【纠错】 【责任编辑:邱丽芳】 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年1月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 中国平安保险（集团）股份有限公司 呈交日期: 2026年2月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | A | | | 於香港聯交所上市 (註1) | | 否 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 601318 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 10,660,065,083 | RMB | | 1 | RMB | | 10,660,065,083 | | 增加 / 減少 (-) | | | | | | | RMB | | | | 本月底結存 | | | 10,660,065,083 | RMB | | | 1 RMB | | 10,660,065,083 | | ...

Core Insights - The meeting held by the China Insurance Industry Association on January 22 focused on the high-quality development of health insurance, emphasizing its role in the multi-tiered medical security system during the "14th Five-Year Plan" period and the need for better integration into the health ecosystem in the "15th Five-Year Plan" [1] Expansion of Coverage - The commercial health insurance sector has seen a compound annual growth rate of over 20% over the past decade, with more than 11,000 medical insurance products available, providing robust support for public health [2] - By 2025, it is estimated that commercial health insurance will incur approximately 14.7 billion yuan in total claims for innovative drugs and medical devices, reflecting a 70% compound annual growth rate over four consecutive years [2] Regulatory Support - The "Guiding Opinions" issued by the National Financial Regulatory Administration aim to optimize existing policies and clarify future directions for health insurance, enhancing support for specialized operations within health insurance companies [3] - The focus is on promoting collaboration between health insurance and the health industry, improving the payment flexibility for innovative drugs and devices [3] Claims Efficiency - In 2025, ZhongAn Insurance reported a total claim payout of 17.9 billion yuan, processing approximately 2.9 million claims daily, with AI technology significantly enhancing the efficiency and user experience of the claims process [4] Infrastructure Development - The China Banking and Insurance Information Technology Management Company is enhancing the infrastructure for health insurance, including product verification, risk control, and claims support, to ensure the industry's stable operation and development [5] Asset Management - As of 2025, insurance asset management products directed towards the medical sector have exceeded 150 billion yuan, with direct investments in healthcare and elderly care nearing 30 billion yuan, supporting various sub-sectors such as biotechnology and medical devices [8] Service Expansion - The establishment of the Health Management Company by PICC aims to integrate health insurance with health management, creating a comprehensive health service network and contributing to the development of long-term care insurance [9] - The collaboration between healthcare and insurance sectors is exemplified by the successful service model of the Peking University Health Group, which has achieved high patient satisfaction rates [10]

证券之星消息，2月2日保险板块较上一交易日下跌2.14%，新华保险领跌。当日上证指数报收于 4015.75，下跌2.48%。深证成指报收于13824.35，下跌2.69%。保险板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 601318 | 中国平安 | 66.02 | -1.09% | 135.45万 | 90.60亿 | | 601319 | 中国人保 | 9.06 | -1.63% | 100.51万 | 9.23亿 | | 601601 | 中国太保 | 44.36 | -2.61% | 37.33万 | 16.84亿 | | 601628 | 中国人寿 | 48.34 | -2.78% | 28.82万 | 14.10 Z | | 601336 | 新华保险 | 80.88 | -2.79% | 23.47万 | 19.347 | 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。 从资金流向 ...

2月首个交易日，市场全天震荡调整，三大指数均跌超2%。截至收盘，沪指跌2.48%，深成指跌2.69%，创业板指跌2.46%。沪深两市成交额2.58万亿，较上 一个交易日缩量2508亿。盘面上，全市场超4600只个股下跌，其中123只个股跌停。从板块来看，白酒概念反复活跃，皇台酒业3连板，金徽酒3天2板，水井 坊触及涨停。电网设备概念逆势走强，汉缆股份、白云电器、三变科技、保变电气等多股涨停。下跌方面，有色金属、油气、化工、煤炭、半导体等板块跌 幅居前。 国联民生证券表示，市场在趋势上行后，窄幅震荡，波动率先升后降，当前或仍需要震荡消化前期涨幅。一方面，本月以沪深300为首的ETF流出较多，对 宽基指数形成压力，大盘风格明显弱于小盘，另一方面，主题轮动加速，部分主题冲高回落，短期小盘、成长占优，但后续有再均衡的需求。中期看，市场 波动率仍较低，仍处于趋势上行的过程中，春季行情仍在延续。随着ETF流出放缓，后续大盘权重股或有补涨的机会。我们认为在当前市场环境下，市场仍 缺乏盈利验证，并且流动性较为充裕，市场仍会灌输各类主题资产和宏大叙事下的投资机会，因而在市场完成调整后，主题资产仍会有新的机会。 浙商证券表示，展 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年1月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 中国平安保险（集团）股份有限公司 呈交日期: 2026年2月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | A | | | 於香港聯交所上市 (註1) | | 否 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 601318 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 10,660,065,083 | RMB | | 1 | RMB | | 10,660,065,083 | | 增加 / 減少 (-) | | | | | | | RMB | | | | 本月底結存 | | | 10,660,065,083 | RMB | | | 1 RMB | | 10,660,065,083 | | ...